Scott Piergrossi
👤 SpeakerAppearances Over Time
Podcast Appearances
And about half of new cancer therapies are derived from the mechanism of action, so the science behind the drug.
So the double L's and the tra suggesting three is so intentional to represent the mechanism of action of the product quite elegantly.
I'm sure you're familiar with Flomax.
So that name was approved in the late 90s, I believe.
And that name is an example of one that probably today would be more challenged.
Because, and this is me speculating, I have no data to say this, but based on the guidance, you know, what is Maximum Flow, right?
A, E, I, O, U all exist in the same visual plane.
And here comes Y with that downstroke quality to it.
So now you're seeing triptyr, I believe was last year's approval.
That's like a double whammy differentiation visually.